{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:59:28Z","timestamp":1790614768573,"version":"4.1.0"},"reference-count":32,"publisher":"CMA Joule Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["cmajo"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.9778\/cmajo.20200232","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T11:25:16Z","timestamp":1638876316000},"page":"E1128-E1133","source":"Crossref","is-referenced-by-count":21,"title":["Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study"],"prefix":"10.9778","volume":"9","author":[{"given":"Jennifer","family":"Fenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"2021120703250642000_9.4.E1128.1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3192558"},{"key":"2021120703250642000_9.4.E1128.2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2016.02.004","article-title":"The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action","volume":"175","author":"Reed","year":"2016","journal-title":"Am Heart J"},{"key":"2021120703250642000_9.4.E1128.3","unstructured":"Drug shortages in Canada (Health Canada, Ottawa) modified 2017 Apr 21. Available: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/drug-shortages.html . accessed 2021 June 18."},{"key":"2021120703250642000_9.4.E1128.4","unstructured":"(2014) Drug shortages: public health threat continues, despite efforts to help ensure product availability (United States Government Accountability Office, Washington (DC)) Available: https:\/\/www.gao.gov\/assets\/670\/660785.pdf . accessed 2021 June 27."},{"key":"2021120703250642000_9.4.E1128.5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00228-014-1747-1","article-title":"Drug shortages in developed countries: reasons, therapeutic consequences, and handling","volume":"70","author":"Dill","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"2021120703250642000_9.4.E1128.6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cjca.2016.08.010","article-title":"Drug shortages: patients and health care providers are all drawing the short straw","volume":"33","author":"Rinaldi","year":"2017","journal-title":"Can J Cardiol"},{"key":"2021120703250642000_9.4.E1128.7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.119.044494","article-title":"Population impact of generic valsartan recall","volume":"141","author":"Jackevicius","year":"2020","journal-title":"Circulation"},{"key":"2021120703250642000_9.4.E1128.8","doi-asserted-by":"crossref","first-page":"e0215837","DOI":"10.1371\/journal.pone.0215837","article-title":"The impacts of medication shortages on patient outcomes: a scoping review","volume":"14","author":"Phuong","year":"2019","journal-title":"PLoS One"},{"key":"2021120703250642000_9.4.E1128.9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pharma.2018.11.007","article-title":"Drug shortages in Canada: data for 2016\u20132017 and perspectives on the problem","volume":"77","author":"Videau","year":"2019","journal-title":"Ann Pharm Fr"},{"key":"2021120703250642000_9.4.E1128.10","unstructured":"Several drugs containing valsartan being recalled due to contamination with a potential carcinogen (Health Canada, Ottawa) modified July 10. Available: https:\/\/www.healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2018\/67202a-eng.php . accessed 2021 June 18."},{"key":"2021120703250642000_9.4.E1128.11","unstructured":"Expansion of recall of valsartan drugs to include additional lots, as a precaution (Health Canada, Ottawa) modified 2018 Dec 18. Available: https:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2018\/67552a-eng.php?_ga=2.186111849.1130786600.1536540324-1989020253.1520525748 . accessed 2021 June 18."},{"key":"2021120703250642000_9.4.E1128.12","doi-asserted-by":"crossref","first-page":"2042098618823458","DOI":"10.1177\/2042098618823458","article-title":"Valsartan recall: global regulatory overview and future challenges","volume":"10","author":"Farrukh","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"2021120703250642000_9.4.E1128.13","unstructured":"Drug shortages homepage (Health Canada, Ottawa) Available: https:\/\/www.drugshortagescanada.ca\/ . accessed 2021 June 18."},{"key":"2021120703250642000_9.4.E1128.14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10557-020-06976-0","article-title":"Reflections of the angiotensin receptor blocker recall by the FDA and repercussions on healthcare","volume":"34","author":"Gillette","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"2021120703250642000_9.4.E1128.15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMp1901657","article-title":"Hypertension hot potato: anatomy of the angiotensin-receptor blocker recalls","volume":"380","author":"Byrd","year":"2019","journal-title":"N Engl J Med"},{"key":"2021120703250642000_9.4.E1128.16","doi-asserted-by":"crossref","first-page":"e0223097","DOI":"10.1371\/journal.pone.0223097","article-title":"Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older","volume":"14","author":"Schwartz","year":"2019","journal-title":"PLoS One"},{"key":"2021120703250642000_9.4.E1128.17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jncimonographs\/lgz036","article-title":"An evaluation of the utility of big data to supplement cancer treatment information: linkage between IQVIA pharmacy database and the Surveillance, Epidemiology, and End Results Program","volume":"2020","author":"Tran","year":"2020","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2021120703250642000_9.4.E1128.18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5770\/cgj.21.307","article-title":"Interprovincial variation of psychotropic prescriptions dispensed to older Canadian adults","volume":"21","author":"Black","year":"2018","journal-title":"Can Geriatr J"},{"key":"2021120703250642000_9.4.E1128.19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcjd.2018.08.190","article-title":"Analysis of trends in insulin utilization and spending across Canada from 2010 to 2015","volume":"43","author":"Xu","year":"2019","journal-title":"Can J Diabetes"},{"key":"2021120703250642000_9.4.E1128.20","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/20.3.808"},{"key":"2021120703250642000_9.4.E1128.21","doi-asserted-by":"publisher","DOI":"10.2307\/2286348"},{"key":"2021120703250642000_9.4.E1128.22","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/65.2.297"},{"key":"2021120703250642000_9.4.E1128.23","first-page":"24","article-title":"Impact of drug shortages on patient safety and pharmacy operation costs","volume":"35","author":"Shaban","year":"2018","journal-title":"Fed Pract"},{"key":"2021120703250642000_9.4.E1128.24","doi-asserted-by":"crossref","first-page":"1370e13","DOI":"10.1016\/j.cjca.2018.08.011","article-title":"Recall of N-nitrosodimethylamine\u2013contaminated pseudogeneric valsartan: Best generics finally no better than others?","volume":"34","author":"Leclerc","year":"2018","journal-title":"Can J Cardiol"},{"key":"2021120703250642000_9.4.E1128.25","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261835"},{"key":"2021120703250642000_9.4.E1128.26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5152\/TurkThoracJ.2018.18014","article-title":"Angiotensin-converting enzyme inhibitors induce cough","volume":"20","author":"Y\u0131lmaz","year":"2019","journal-title":"Turk Thorac J"},{"key":"2021120703250642000_9.4.E1128.27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1715163520929387","article-title":"Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic","volume":"153","author":"Elbeddini","year":"2020","journal-title":"Can Pharm J (Ott)"},{"key":"2021120703250642000_9.4.E1128.28","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bcp.13624","article-title":"Stakeholders\u2019 views and experiences of pharmacist prescribing: a systematic review","volume":"84","author":"Jebara","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2021120703250642000_9.4.E1128.29","doi-asserted-by":"publisher","DOI":"10.12968\/bjcn.2008.13.12.31830"},{"key":"2021120703250642000_9.4.E1128.30","unstructured":"(2010) Special issue: Drug shortages \u2014 National survey reveals high level of frustration, low level of safety (Institute for Safe Medication Practices (ISMP), Horsham (PA)) https:\/\/www.ismp.org\/resources\/special-issue-drug-shortages-national-survey-reveals-high-level-frustration-low-level . accessed 2021 June 18."},{"key":"2021120703250642000_9.4.E1128.31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.119.13955","article-title":"Current status of angiotensin receptor blocker recalls","volume":"74","author":"Gunasekaran","year":"2019","journal-title":"Hypertension"},{"key":"2021120703250642000_9.4.E1128.32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/poms.12697","article-title":"Mitigating the US drug shortages through pareto-improving contracts","volume":"26","author":"Jia","year":"2017","journal-title":"Prod Oper Manag"}],"container-title":["CMAJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.9778\/cmajo.20200232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T11:25:45Z","timestamp":1638876345000},"score":1,"resource":{"primary":{"URL":"http:\/\/cmajopen.ca\/lookup\/doi\/10.9778\/cmajo.20200232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,7]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.9778\/cmajo.20200232"],"URL":"https:\/\/doi.org\/10.9778\/cmajo.20200232","relation":{},"ISSN":["2291-0026"],"issn-type":[{"value":"2291-0026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}